ALFA Finder
18:16 IST
BSE
Board Meeting Date
Concord Drugs Board Meeting Date
Concord Drugs will hold a board meeting on 12 November 2026 to consider September 2026 half-year results. Trading window is closed until 15 November 2026.
Concord Drugs Ltd
- Share price
- ₹71.11
- Market cap
- ₹93.69 Cr
- Revenue (annual)
- ₹78.74 Cr
- Net profit (annual)
- ₹1.06 Cr
- P/E (TTM)
- 45.7×Sector 43.8×
- Promoter holding
- 45.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
6 announcements with these filters
16:53 IST
BSE
Other Announcement
Concord Drugs Other Announcement
Concord Drugs Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
20:47 IST
BSE
Annual General Meeting
Concord Drugs Annual General Meeting
Concord Drugs Limited held its 31st Annual General Meeting on September 30, 2026. The meeting covered adoption of financial statements, director appointments, and auditor re-appointment.
19:33 IST
BSE
Other Announcement
Concord Drugs Other Announcement
Concord Drugs Limited is notifying shareholders about the annual report web-link as per Regulation 36(1)(b). Shareholders are urged to update their email addresses.
19:21 IST
BSE
Annual Report
Concord Drugs Annual Report
Concord Drugs Limited submitted its 31st Annual Report for FY 2025-26 and notice of the 31st Annual General Meeting scheduled for 30th September 2026.
19:12 IST
BSE
Annual General Meeting
Concord Drugs Annual General Meeting
Concord Drugs approved the notice for its 31st AGM on September 30, 2026. The board also finalized director re-appointments and set book closure dates.